This group includes a mammalian target of rapamycin (mTOR), DNA-dependent protein kinase (DNA-PK), ataxia telangiectasia mutated gene product (ATM), and ataxia telangiectasia and Rad3-related gene product [79]. Here, MTOR is linked to Telangiectasia.